MartÃnez-Alonso, E.; Escobar-Peso, A.; Ayuso, M.I.; Gonzalo-Gobernado, R.; Chioua, M.; Montoya, J.J.; Montaner, J.; Fernández, I.; Marco-Contelles, J.; Alcázar, A.
Characterization of a CholesteroNitrone (ISQ-201), a Novel Drug Candidate for the Treatment of Ischemic Stroke. Antioxidants 2020, 9, 291.
https://doi.org/10.3390/antiox9040291
AMA Style
MartÃnez-Alonso E, Escobar-Peso A, Ayuso MI, Gonzalo-Gobernado R, Chioua M, Montoya JJ, Montaner J, Fernández I, Marco-Contelles J, Alcázar A.
Characterization of a CholesteroNitrone (ISQ-201), a Novel Drug Candidate for the Treatment of Ischemic Stroke. Antioxidants. 2020; 9(4):291.
https://doi.org/10.3390/antiox9040291
Chicago/Turabian Style
MartÃnez-Alonso, Emma, Alejandro Escobar-Peso, Maria I. Ayuso, Rafael Gonzalo-Gobernado, Mourad Chioua, Juan J. Montoya, Joan Montaner, Israel Fernández, José Marco-Contelles, and Alberto Alcázar.
2020. "Characterization of a CholesteroNitrone (ISQ-201), a Novel Drug Candidate for the Treatment of Ischemic Stroke" Antioxidants 9, no. 4: 291.
https://doi.org/10.3390/antiox9040291
APA Style
MartÃnez-Alonso, E., Escobar-Peso, A., Ayuso, M. I., Gonzalo-Gobernado, R., Chioua, M., Montoya, J. J., Montaner, J., Fernández, I., Marco-Contelles, J., & Alcázar, A.
(2020). Characterization of a CholesteroNitrone (ISQ-201), a Novel Drug Candidate for the Treatment of Ischemic Stroke. Antioxidants, 9(4), 291.
https://doi.org/10.3390/antiox9040291
